Ibipolid 2mg Capsule is a medication used in the treatment of multiple myeloma, a type of cancer affecting plasma cells in adults. It contains Pomalidomide, which falls into the category of Immunomodulating agents. Typically, it is prescribed alongside other anti-cancer drugs like dexamethasone and/or bortezomib to enhance its effectiveness.

Before starting a course of Ibipolid 2mg Capsule, it is crucial to inform your healthcare provider about any existing liver, kidney, or heart conditions you may have. Additionally, disclose if you suffer from high blood pressure, high blood cholesterol levels, blood clots, hepatitis B infection, or if you are a smoker as precautionary measures.

This medication is not suitable for use by pregnant women or those planning a pregnancy, unless directed by a physician. Breastfeeding women should only take Ibipolid 2mg Capsule if deemed necessary by a medical professional. Both men and women undergoing treatment with this medicine are advised to use effective contraception to prevent pregnancy before, during, and up to 4 weeks after stopping the therapy. It is also important to note that individuals on this medication should refrain from donating blood during treatment and for 7 days post-treatment.

Common side effects associated with Ibipolid 2mg Capsule may include increased susceptibility to infections, decreased red blood cell and platelet counts, nausea, vomiting, swelling in body parts, numbness or tingling sensations, skin rashes, oral sores, alterations in taste, and weight loss. If any of these side effects become bothersome, it is advisable to consult your healthcare provider for guidance.